This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovations of Stephane Theophile Temmerman
Introduction
Stephane Theophile Temmerman is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of immunology, particularly through his innovative approaches to inducing immune responses.
Latest Patents
Temmerman holds a patent for "Methods for inducing an immune response." This patent outlines methods and uses for inducing an immune response that involves at least two administrations of an immunogenic composition containing an M72 related antigen, with a subsequent administration being delayed. This innovative approach has the potential to enhance vaccine efficacy and improve patient outcomes.
Career Highlights
Temmerman is currently associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical and biotechnology sector. His work at GlaxoSmithKline focuses on developing advanced immunological therapies that can address various health challenges.
Collaborations
Throughout his career, Temmerman has collaborated with esteemed colleagues, including William Ripley Ballou, Jr. and Marie-Ange Demoitie. These collaborations have fostered a rich exchange of ideas and have contributed to the advancement of immunological research.
Conclusion
Stephane Theophile Temmerman is a distinguished inventor whose work in immunology has the potential to make a significant impact on public health. His innovative methods for inducing immune responses reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile